Supplemental Figure 1 from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Stephen M. Ansell,Michael B. Maris,Alexander M. Lesokhin,Robert W. Chen,Ian W. Flinn,Ahmed Sawas,Mark D. Minden,Diego Villa,Mary‐Elizabeth M. Percival,Anjali S. Advani,James M. Foran,Steven M. Horwitz,Matthew Mei,Jasmine Zain,Kerry J. Savage,Christiane Querfeld,Oleg E. Akilov,Lisa D. Johnson,Tina Catalano,Penka S. Petrova,Robert A. Uger,Eric L. Sievers,Anca Milea,Kathleen Roberge,Yaping Shou,Owen A. O’Connor openalex
AI 理解论文
溯源树
样例
